SciELO - Scientific Electronic Library Online

 
vol.16 issue3Recurrent Hyperammonemia After Abernethy Malformation Type 2 Closure: a Case Report author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Annals of Hepatology

Print version ISSN 1665-2681

Abstract

WAISBOURD-ZINMAN, Orith et al. A Rare BSEP Mutation Associated with a Mild Form of Progressive Familial Intrahepatic Cholestasis Type 2. Ann. Hepatol. [online]. 2017, vol.16, n.3, pp.465-468. ISSN 1665-2681.  https://doi.org/10.5604/16652681.1235494.

Progressive Familial Intrahepatic Cholestasis type 2 (PFIC2) is a rare cholestatic disorder diagnosed in infancy or childhood that can lead to severe hepatic fibrosis and liver failure. Mutations in the ABCB11 gene result in a deficiency of the bile salt export protein (BSEP) and accumulation of bile inside the hepatocytes. Hepatocellular carcinoma is another condition associated with severe forms of deletion mutations in the ABCB11 gene. Treatment options including ursodeoxycholic acid biliary diversion have mixed outcomes and some patients require liver transplantation. Here, we describe two siblings with an extremely mild form of PFIC2 inherited from heterozygous parents. The elder sibling had acute liver failure at the age of six months and both siblings had pruritus, cholestasis, coagulopathy and fat-soluble-vitamin deficiencies in infancy but have been asymptomatic past infancy. Genetic testing of the siblings revealed that each were compound heterozygotes for two missense mutations of the ABCB11 gene: p.C68Y and p.R832H. Medical treatment typical for PFIC2 has not been necessary for either patient. This is the first report of these variants following a mild course in two affected patients.

Keywords : Cholestasis; PFIC2; Progressive Familial Intrahepatic Cholestasis; ABCB11; BSEP.

        · text in English     · English ( pdf )